Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -84,350 | -55,064 | -25,283 | -93,922 |
| Depreciation Amortization | 1,062 | 722 | 356 | 1,745 |
| Accounts payable and accrued liabilities | 1,142 | 1,338 | 1,362 | N/A |
| Other Working Capital | 113 | -218 | -4,010 | 1,465 |
| Other Operating Activity | 7,682 | 4,175 | 1,146 | 9,494 |
| Operating Cash Flow | $-74,351 | $-49,047 | $-26,429 | $-81,218 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,622 | -462 | -162 | -1,404 |
| Investing Cash Flow | $-1,622 | $-462 | $-162 | $-1,404 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 75,973 | 49,509 | 26,591 | 82,622 |
| Financing Cash Flow | $75,973 | $49,509 | $26,591 | $82,622 |
| Net Cash Flow | $N/A | $0 | $0 | $0 |
| Free Cash Flow | ||||
| Operating Cash Flow | -74,351 | -49,047 | -26,429 | -81,218 |
| Capital Expenditure | -1,622 | -462 | -162 | N/A |
| Free Cash Flow | -75,973 | -49,509 | -26,591 | -81,218 |